Serial Number 97932287
Registration 7339894
700

Registration Progress

Application Filed
May 11, 2023
Under Examination
Approved for Publication
Jan 9, 2024
Published for Opposition
Jan 9, 2024
Registered
Mar 26, 2024

Trademark Image

Basic Information

Serial Number
97932287
Registration Number
7339894
Filing Date
May 11, 2023
Registration Date
March 26, 2024
Published for Opposition
January 9, 2024
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 26, 2024
Registration
Registered
Classes
005

Rights Holder

Takeda Pharmaceuticals International AG

03
Address
Thurgauerstrasse 130
Glattpark-Opfikon 8152
CH

Ownership History

Takeda Pharmaceuticals International AG

Original Applicant
03
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Owner at Publication
03
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Original Registrant
03
Glattpark-Opfikon CH

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

Next Deadline
1702 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-03-26)
Due Date
March 26, 2030
Grace Period Ends
September 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

17 events
Date Code Type Description Documents
Mar 26, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 26, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 9, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 20, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 6, 2023 ALIE A ASSIGNED TO LIE Loading...
Dec 6, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 6, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 6, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 5, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jun 24, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 24, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jun 24, 2023 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Jun 24, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jun 13, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 11, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 15, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of neurological diseases
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of six shaded leaf shapes overlapping in an upward arc.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005